Invest Ontario is supporting Roche Canada’s more than $130M investment to create up to 250 jobs in AI, machine learning, computational biology and data analytics.
Biopharma and Vaccines
Where Biopharma and Vaccines drive discoveries
Take charge in Ontario, a top hub for biopharmaceutical advancements, where global leaders and innovative startups discover and bring life-changing innovations to market. Benefit from top talent, world-class research partners, and strong R&D support. Shape the future of biopharma and vaccines right here in Ontario, where your ideas can make a real difference.
A measurable difference
$1.82B
invested in R&D by Ontario’s research hospitals
#1
Canada ranks #1 in active clinical trials per capita among G7 nations
#1
largest life sciences jurisdiction in Canada
$77B+
revenue in Ontario’s life sciences sector in 2022
72,800
life sciences workers in Ontario in 2022
12.5B
Ontario’s life sciences exported goods in 2022
61.7%
of total Canadian life sciences sector exports
~2,000
Ontario life sciences firms (44% of Canada’s total)
Get the Prescription for Success in Ontario
An R&D Powerhouse
Experience thriving clinical trials and rapid commercialization of cutting-edge therapies in Ontario. Benefit from cost advantages, a diverse population, and streamlined processes, making Ontario ideal for your biomanufacturing needs. Notably, all of the world’s top ten pharmaceutical companies by revenue, including Johnson & Johnson, Roche, Novartis, Merck & Co, Pfizer, conduct clinical trials in Ontario. Witness groundbreaking investment, like OmniaBio’s $580 million in Brampton, advancing Canada’s cell and gene therapy manufacturing capabilities.
Ontario’s Biopharma Talent Pool
Leverage Ontario’s pool of top-tier medical and scientific talent to drive your biopharmaceutical business forward. With a steady influx of over 70,000 STEM graduates annually and a robust academic ecosystem focusing on biotechnology and life sciences, Ontario provides a rich talent pool for your company’s growth and innovation needs. Tap into this skilled workforce to advance your biopharma initiatives and propel your business to new heights of success.
$3.39 billion
attracted by Ontario Universities for research
25,000+
researchers employed by Ontario’s research hospitals
A Uniquely Collaborative Ecosystem
Engage with Ontario’s collaborative innovation ecosystem, where industry, academia, and government converge to catalyze revolutionary advancements in biopharmaceuticals. Partner with world-renowned research institutions to pioneer discoveries and leverage government initiatives supporting research translation into clinical applications.
Ontario’s fertile ground has witnessed pioneering breakthroughs like insulin, the first meningitis vaccine for infants, the first HIV vaccine, and the prototype of 3D bioprinting to print artificial skin, Join this transformative landscape to revolutionize the biopharmaceutical industry and propel your business to new heights of success.
Why do we invest in Ontario? When we look at Ontario, the unique blend of academic institutions, research centres and hospitals create a deep and diverse talent base. With that great talent pool, we are able to deliver unbelievable results.
Gaby Bourbara
Country President, AstraZeneca Canada
In good company
CONCOCT THE CURE IN ONTARIO
Discover Ontario’s growing life sciences sector with AstraZeneca’s announcement of investment in clinical trials bringing 500 new jobs in Peel and the surrounding region.
The Ontario government has concluded a successful trade mission to India to strengthen relationships with economic partners and attract new investments in key sectors.
Invest Ontario was at BIO 2023 to promote the province’s growing life sciences and biotech sector and explore new opportunities for investment.
Engineer the Evolution of Biopharma and Vaccines in Ontario